Annual Operating Profit
-$69.64 M
-$27.37 M-64.77%
December 31, 2023
Summary
- As of February 8, 2025, ANTX annual operating income is -$69.64 million, with the most recent change of -$27.37 million (-64.77%) on December 31, 2023.
- During the last 3 years, ANTX annual operating profit has fallen by -$62.35 million (-856.00%).
- ANTX annual operating profit is now -856.00% below its all-time high of -$7.28 million, reached on December 31, 2020.
Performance
ANTX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$11.77 M
+$4.11 M+25.88%
September 30, 2024
Summary
- As of February 8, 2025, ANTX quarterly operating income is -$11.77 million, with the most recent change of +$4.11 million (+25.88%) on September 30, 2024.
- Over the past year, ANTX quarterly operating profit has increased by +$6.53 million (+35.66%).
- ANTX quarterly operating profit is now -474.20% below its all-time high of -$2.05 million, reached on March 31, 2021.
Performance
ANTX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$64.76 M
+$6.41 M+9.01%
September 30, 2024
Summary
- As of February 8, 2025, ANTX TTM operating income is -$64.76 million, with the most recent change of +$6.41 million (+9.01%) on September 30, 2024.
- Over the past year, ANTX TTM operating profit has increased by +$7.13 million (+9.92%).
- ANTX TTM operating profit is now -3059.12% below its all-time high of -$2.05 million, reached on March 31, 2021.
Performance
ANTX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
ANTX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -64.8% | +35.7% | +9.9% |
| 3 y3 years | -856.0% | +35.7% | +9.9% |
| 5 y5 years | -856.0% | +35.7% | +9.9% |
ANTX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -222.8% | at low | -55.0% | +37.4% | -200.2% | +9.9% |
| 5 y | 5-year | -856.0% | at low | -474.2% | +37.4% | -3059.1% | +9.9% |
| alltime | all time | -856.0% | at low | -474.2% | +37.4% | -3059.1% | +9.9% |
AN2 Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$11.77 M(-25.9%) | -$64.76 M(-9.0%) |
| Jun 2024 | - | -$15.88 M(-13.2%) | -$71.17 M(-1.0%) |
| Mar 2024 | - | -$18.30 M(-2.8%) | -$71.89 M(+3.2%) |
| Dec 2023 | -$69.64 M(+64.8%) | -$18.82 M(+3.5%) | -$69.64 M(+10.0%) |
| Sep 2023 | - | -$18.18 M(+9.5%) | -$63.30 M(+11.3%) |
| Jun 2023 | - | -$16.60 M(+3.5%) | -$56.89 M(+12.4%) |
| Mar 2023 | - | -$16.04 M(+28.6%) | -$50.62 M(+19.8%) |
| Dec 2022 | -$42.26 M | -$12.48 M(+6.0%) | -$42.26 M(+13.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$11.77 M(+13.9%) | -$37.38 M(+14.9%) |
| Jun 2022 | - | -$10.33 M(+34.5%) | -$32.54 M(+19.6%) |
| Mar 2022 | - | -$7.68 M(+1.2%) | -$27.21 M(+26.1%) |
| Dec 2021 | -$21.57 M(+196.2%) | - | - |
| Dec 2021 | - | -$7.59 M(+9.5%) | -$21.57 M(+54.3%) |
| Sep 2021 | - | -$6.93 M(+38.7%) | -$13.98 M(+98.4%) |
| Jun 2021 | - | -$5.00 M(+143.8%) | -$7.05 M(+243.8%) |
| Mar 2021 | - | -$2.05 M | -$2.05 M |
| Dec 2020 | -$7.28 M | - | - |
FAQ
- What is AN2 Therapeutics annual operating income?
- What is the all time high annual operating profit for AN2 Therapeutics?
- What is AN2 Therapeutics annual operating profit year-on-year change?
- What is AN2 Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for AN2 Therapeutics?
- What is AN2 Therapeutics quarterly operating profit year-on-year change?
- What is AN2 Therapeutics TTM operating income?
- What is the all time high TTM operating profit for AN2 Therapeutics?
- What is AN2 Therapeutics TTM operating profit year-on-year change?
What is AN2 Therapeutics annual operating income?
The current annual operating profit of ANTX is -$69.64 M
What is the all time high annual operating profit for AN2 Therapeutics?
AN2 Therapeutics all-time high annual operating income is -$7.28 M
What is AN2 Therapeutics annual operating profit year-on-year change?
Over the past year, ANTX annual operating income has changed by -$27.37 M (-64.77%)
What is AN2 Therapeutics quarterly operating income?
The current quarterly operating profit of ANTX is -$11.77 M
What is the all time high quarterly operating profit for AN2 Therapeutics?
AN2 Therapeutics all-time high quarterly operating income is -$2.05 M
What is AN2 Therapeutics quarterly operating profit year-on-year change?
Over the past year, ANTX quarterly operating income has changed by +$6.53 M (+35.66%)
What is AN2 Therapeutics TTM operating income?
The current TTM operating profit of ANTX is -$64.76 M
What is the all time high TTM operating profit for AN2 Therapeutics?
AN2 Therapeutics all-time high TTM operating income is -$2.05 M
What is AN2 Therapeutics TTM operating profit year-on-year change?
Over the past year, ANTX TTM operating income has changed by +$7.13 M (+9.92%)